RespireRx Pharmaceuticals Inc (RSPI)

[K-G]

Could also be related to Organon. Here is a news release from last week.

AMSTERDAM, March 1 (Reuters) - Dutch chemical group Akzo Nobel NV (AKZO.AS: Quote, Profile , Research)(AKZOY.O: Quote, Profile , Research) said on Thursday it was cutting the size of its board to eight from 10 members as a result of its plans to spin off its Organon pharmaceutical business.

Akzo said in a statement Toon Wilderbeek, board member responsible for pharma, has left to concentrate fully on his role as chief executive of Organon BioSciences, 20-30 percent of which it plans to list before the end of March.

It added that Cees van Lede, Abraham Cohen and Alain Merieux would be leaving the board on May 1, while Peggy Bruzelius, former chief executive of ASEA Brown Boveri, would be appointed to the board for a four-year term.

The annual shareholders meeting on April 25 will be asked to approve the changes.

At a meeting on Wednesday, Akzo said the board also formally decided to divest a minority stake in Organon.

Akzo said earlier this week investor pre-marketing for the Organon listing was planned for the first two weeks of March, with a management roadshow expected to start shortly after that.

Organon and Intervet, the units that will form Organon BioSciences, together realised a fourth-quarter operating profit of 127 million euros.

© Reuters 2007. All Rights Reserved.